Article
Regulators of Androgen Action Resource: a one-stop shop for the comprehensive study of androgen receptor action
14 Feb 2016
Abstract excerpt
Androgen receptor (AR) is a ligand-activated transcription factor that is the main target for treatment of non-organ-confined prostate cancer (CaP). Failure of life-prolonging AR-targeting androgen deprivation therapy is due to flexibility in steroidogenic pathways that control intracrine androgen levels and variability in the AR transcriptional output. Androgen biosynthesis enzymes, androgen transporters and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
